P4ML Joins Orphan Therapeutics Accelerator to Enhance Rare Disease Treatment Access P4ML has become a Founding Member of the OTXL to improve global access to treatments for ultra-rare diseases, leveraging innovative strategies.

P4ML Joins Orphan Therapeutics Accelerator to Enhance Rare Disease Treatment Access #Dubai #UAE #P4ML #OTXL #Genomic_Therapy

American Society of Gene & Cell Therapy and Orphan Therapeutics… First-of-its-kind venture to facilitate and catalyze development of deprioritized cell and gene therapies, supported by AI-enabled platform

We’re proud to announce a new partnership with Orphan Therapeutics Accelerator to launch CGTxchange – a first-of-its-kind, jointly owned marketplace for deprioritized CGTs, accelerating development for ultra-rare diseases. #ASGCT #OTXL

Learn more: https://bit.ly/3LuypaS

How Orphan Therapeutics Accelerator Is Optimizing Rare Disease Search & Eval How Orphan Therapeutics Accelerator uses Vibe Bio for rare disease due diligence, pipeline & competitive analysis, & in-licensing strategy.

Rare disease teams face too much noise and not enough clarity. The Orphan Therapeutics Accelerator helps biotechs identify promising rare disease programs with speed + rigor.

Our new case study shows how Vibe Bio’s AI platform made that possible.

vibebio.com/blog/orphan-...
#AI #raredisease #otxl